Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Board of Directors

Governance Overview | Management Team | Board of Directors | Committee Composition | Contact Lead Director

James C. Foster
Chairman, President & Chief Executive Officer
Robert J. Bertolini
Former President & Chief Financial Officer, Bausch & Lomb Incorporated
Stephen D. Chubb
Former Chairman & Chief Executive Officer, Matritech, Inc.
Deborah T. Kochevar, D.V.M., Ph.D., D.A.C.V.C.P.
Provost and Senior Vice President ad interim, Tufts University
Martin Mackay, Ph.D.
Former Executive Vice President, Alexion Pharmaceuticals Inc.
Jean-Paul Mangeolle
Former President, AB Sciex
George E. Massaro
Vice Chairman, Huron Consulting Group, Inc.
George M. Milne, Jr., Ph.D.
Retired Executive Vice President of Global Research and Development, & President of Central Research, Pfizer Inc.
C. Richard Reese
Former Chairman & Chief Executive Officer, Iron Mountain Incorporated
Richard F. Wallman
Former Senior Vice President & Chief Financial Officer, Honeywell International, Inc.

Stock Quote

CRL (common)
Price
$145.12
Change (%)
- 0.69 (0.47%)
Volume
207,845
Exchange
NYSE
Data as of 03/20/19 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)